title: Where to go next with neuroprotection in multiple sclerosis?
authors.forename: Franz
authors.initials: F
authors.lastname: Fazekas
mesh_terms: D002544:Cerebral Infarction / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D009069:Movement Disorders / Q000188:drug therapy / Q000209:etiology; D009103:Multiple Sclerosis / Q000150:complications / Q000188:drug therapy*; D018696:Neuroprotective Agents / Q000627:therapeutic use*
chemical_list: D018696:Neuroprotective Agents